Is a complete VRXA research report available?

No complete published report is available for Veraxa Biotech AG (VRXA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Veraxa Biotech AG (VRXA)

NASDAQ: VRXA · USD

$1.96

-0.01 (-0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VRXA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	49.4M
Shares out	25.2M
Volume	91,169

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 49.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-07-31 02:00 UTC

All VRXA indicators

Market & fundamental data

Available fields

Groups with data

Currency

USD

Showing 96 of 96 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002079109
Company name	Veraxa Biotech AG
Country	Germany
Country code	US
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-12
Industry	Biotechnology
Isin	CH1476899161
Last refreshed	2026-07-31
Market cap	$49.4M
Market cap category	Nano-Cap
Price	$1.96
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	VRXA
Website	https://www.veraxa.com

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income Growth Years	0%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-81.18%
EPS Growth Years	0
Revenue Growth Years	0x

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-81.15%
200-day SMA	9.92
50-day SMA	6.58
50-day SMA vs 200-day SMA	50under200
All Time High	27.36
All Time High Change	-92.84%
All Time High Date	2026-06-11
All Time Low	1.7
All Time Low Change	15.29%
All Time Low Date	2026-07-01
ATR	0.76
Beta1y	0.14
Beta2y	0.07
Ch YTD	-81.63
High	2.02
High52	27.36
High52 Date	2026-06-11
High52ch	-92.84%
Low	1.93
Low52	1.7
Low52 Date	2026-07-01
Low52ch	15.29%
Ma50ch	-70.23%
Premarket Change Percent	-2.03
Premarket Price	$1.93
Premarket Volume	4,398
Price vs 200-day SMA	-80.25%
RSI	36.8
RSI Monthly	17.43
RSI Weekly	35.06
Sharpe ratio	-0.61x
Sortino ratio	-0.77
Tr YTD	-81.63
Tr1m	-9.68%
Tr1w	5.38%
Tr3m	-84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Institutions	0.13%
Shares Out	25,217,315
Short Ratio	0.22
Short Shares	0.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	994,510.4x
Ch1m	-9.68
Ch1w	5.38
Ch1y	-81.15
Ch3m	-84
Ch6m	-81.63
Change	-0.51%
Change From Open	-1.51
Close	1.97
Days Gap	1.02
Dollar Volume	178,691.2
F Score	0
Founded	2,021
Is Primary Listing	1
Is Spac	No
Last Split Type	Never
Last10k Filing Date	2026-06-16
Ma150	9.73
Ma150ch	-79.85%
Ma20	2.16
Ma20ch	-9.13%
Open	1.99
Position In Range	33.33
Post Close	1.96
Postmarket Change Percent	0.32
Postmarket Price	$1.97
Pre Close	1.97
Price Date	2026-07-30
Relative Volume	0.09x
Tr6m	-81.63%
Volume	91,169